We’re pleased to announce the launch of the official website of the Circulating Tumor Cell–Derived Neoantigen Peptide Study Group.
We will continue to share updates and information we hope you will find useful. Thank you for your continued support.
Circulating Tumor Cell–Derived Neoantigen Peptide Study Group Website Now Live
- Notice of Becoming a Wholly Owned Subsidiary
- Notice to Participants Who Took Part in the Feasibility Study of Neoantigen DC Therapy
関連記事
-
Many Neoantigen Candidates Identified by Isolating Circulating Tumor Cells (CTCs) from Blood and Performing Genomic Analysis—Paper Published -
Notice to Participants Who Took Part in the Feasibility Study of Neoantigen DC Therapy
-
Notice of Becoming a Wholly Owned Subsidiary
-
A project to promote “custom-made” medical care using genomic information has been launched
-
PCT international application filed
-
Announcement of website launch
